Whole Foods Market (NASDAQ: WFMI) today launches the first in-store color-coded sustainability-rating program for wild-caught seafood and commits to phasing out all red-rated species by Earth Day 2013. Through partnerships with Blue Ocean Institute and Monterey Bay Aquarium, Whole Foods Market is the first national grocer to provide a comprehensive sustainability rating system for wild-caught seafood.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/wholefoodsmarket/45932/
Altera Corporation (NASDAQ: ALTR) today announced it has achieved a significant milestone in transceiver technology by becoming the first company to successfully demonstrate 25-Gbps transceiver performance in programmable logic. Altera achieved this milestone in its 28-nm transceiver test chip, a prototyping platform that Altera is using to succeassfully deploy 28-Gbps transceivers on 28-nm FPGAs. Reaching the 25-Gbps milestone more than doubles the transceiver performance in currently available FPGA solutions, and rivals or exceeds the abilities of competitive ASSP offerings. A demonstration video of the 28-nm transceiver test chip is available for viewing on Altera's website.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/altera/43983/
Qualcomm Incorporated (NASDAQ: QCOM) today announced that its Snapdragon™ processors are enabling the latest and greatest multimedia experiences in today’s commercial mobile devices, including stereoscopic 3D (S3D) entertainment, 1080p 30fps HD video capture and playback, console-quality gaming and full web browsing with Adobe Flash 10. The newest member of the Snapdragon family, Qualcomm’s APQ8060 dual-CPU processor, powers the HP TouchPad, which HP introduced yesterday.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/qualcomm/48634/
E*TRADE Financial Corporation (NASDAQ: ETFC) today announced that E*TRADE Securities LLC has unveiled a new 30-second “Talking Baby” advertisement which will run during the NBC® television network broadcast of Super Bowl XLVI.
The Super Bowl spot, entitled “Fatherhood,” features the E*TRADE Baby reassuring a nervous new dad about planning for his newborn daughter’s future with help from Financial Consultants at E*TRADE.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54519-e-trade-commercial-baby-super-bowl-advertisements-ads
The Johns Hopkins University Applied Physics Laboratory (APL), with help from The Boeing Company [NYSE: BA] and Iridium Communications Inc. [Nasdaq: IRDM], has successfully implemented a new space-based system to monitor Earth’s space environment. Known as the Active Magnetosphere and Planetary Electrodynamics Response Experiment (AMPERE), the system provides real-time magnetic field measurements using commercial satellites as part of a new observation network to forecast weather in space. This is the first step in developing a system that enables 24-hour tracking of Earth's response to supersonic blasts of plasma ejected from the sun at collection rates fast enough to one day enable forecasters to predict space weather effects.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/iridium/45153/
Qualcomm Incorporated (NASDAQ: QCOM), a leading developer and innovator of advanced wireless technologies, products and services, today announced that it will showcase some of the latest innovations and ideas that are enabling access, control and interaction with the digital world during the GSMA Mobile World Congress 2011 (Booth 8B53, Hall 8), Feb. 14-17 in Barcelona. The Company’s demonstrations will feature next-generation mobile technologies and services designed to drive today’s and the future’s most advanced mobile devices and experiences. Highlights of the exhibit include LTE Advanced, HSPA+ Advanced, augmented reality, devices based on the Snapdragon™ mobile computing platform, WiPower™ and the Internet of Everything Module (IEM) design for enabling the “Internet of Everything.”
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/qualcomm/48665/
Today Walgreens (NYSE, NASDAQ: WAG), announced the Walgreens Way to Well Health Tour with AARP, a program dedicated to providing free prevention and early detection health services to some of the nation’s most underserved communities. Now through December 2012, the tour will provide free tests, assessments, education and consulting services to communities located predominantly in cities with the highest prevalence for leading diseases, and highest uninsured and unemployed populations.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54970-walgreens-way-to-well-health-tour-with-aarp
Cirque du Soleil, in partnership with Elvis Presley Enterprises, a CKX, Inc (NASDAQ: CKXE) company, celebrates the world premiere of its latest resident show Viva ELVIS™, at ARIA Resort & Casino™ at CityCenter in Las Vegas tonight.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/cirque/42112/
Solta Medical, Inc. (Nasdaq: SLTM), a global leader in the medical aesthetics market and manufacturer of the industry's three premier brands: Thermage®, Fraxel®, and Isolaz®, is pleased to announce that it has partnered with PGA TOUR golfer Scott McCarron to raise awareness about skin protection and the Fraxel re:store® laser treatment. As the leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin, including the removal of actinic keratoses (AK’s ) — a precancerous skin condition caused by sun exposure. Fraxel re:store treatment provides superior results for AKs on the face or other areas of the body displaying the signs of photodamage.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/solta/45388/
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s antibacterial drug DIFICID™ (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older. CDAD is a significant medical problem in hospitals and long-term care facilities, and is beginning to emerge in the community among people previously at low risk for the disease. In the largest Phase 3 clinical studies ever conducted in CDAD, DIFICID had clinical response rates at the end of treatment that were non-inferior to oral vancomycin. DIFICID was superior to vancomycin in sustaining clinical response through 25 days beyond the end of treatment. DIFICID is the only FDA-approved antibacterial drug proven to be superior to vancomycin in sustained clinical response for CDAD.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/optimerpharma/50177/
Imagine a device worn on your finger that allows intuitive, touch-free interaction with the digital world. Imagine a solar panel the size of a microcontroller that enables environmental intelligence in any building. Imagine integrating carbon monoxide sensing, thermostat control and biometric security capabilities to a smoke detector without increasing its size. This smarter, greener, battery-free world is fast becoming a reality with the world’s lowest-power microcontroller platform from Texas Instruments Incorporated (TI) (NASDAQ: TXN). Codenamed “Wolverine” for its aggressive power-saving technology, this ultra-low-power MSP430 microcontroller platform offers at least 50 percent less power consumption than any other microcontroller in the industry (360 nA real-time clock mode and less than 100 µA/MHz active power consumption). The first devices based on this platform will be the MSP430FR58xx microcontroller series with expected availability in June 2012.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54041-texas-instruments-ti-wolverine-microcontroller-platform
Today, Solta Medical, Inc. (Nasdaq: SLTM), the pioneer in fractional resurfacing and non-invasive skin tightening and a global market leader in aesthetic treatments, announced the arrival of its groundbreaking Liposonix technology in the United States and Canada. Using advanced high-intensity focused ultrasound (HIFU) technology, Liposonix is a non-surgical permanent fat reduction procedure that has been clinically shown to slim down the waistline by one pant or dress size without surgery or downtime. It is indicated for non-invasive waist circumference reduction for use on both the abdomen and love handles.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54037-solta-liposonix-custom-contouring-waistline-fat-reduction
